☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
MC2 Therapeutics
MC2 Therapeutics Entered into an Agreement with Huadong to Develop and Commercialize Wynzora Cream in Greater China
September 1, 2023
Insights+: The US FDA New Drug Approvals in July 2020
August 27, 2020
MC2 Therapeutics Wynzora Cream Receives the US FDA's Approval to Treat Plaque Psoriasis in Adults
July 22, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.